Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Clinical Effectiveness and Long-Term Serologic Responses of COVID-19 Vaccination in Patients with Multiple Myeloma and Waldenström Macroglobulinemia

Blood (2022) 140 (Supplement 1): 10094–10096.

https://doi.org/10.1182/blood-2022-167899

Published: 2022

Journal Articles

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rie Nakamoto-Matsubara, Valentina Nardi, Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, Rakesh Verma, Andrew J. Yee, Andrew R. Branagan, Elizabeth O'Donnell, Noopur S. Raje

Blood (2021) 138 (Supplement 1): 398.

https://doi.org/10.1182/blood-2021-152784

Published: 2021

Journal Articles

OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy

Paul-Joseph Aspuria, Michael A Bauer, PhD, Sandro vivona, Rene de Waal Malefyt, Rob Kastelein, Martin Oft, Jan Emmerich, Deepti Rokkam, Steven E Kauder, PhD, Scott McCauley, Romina Riener, Rakesh Verma, PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-143483

Published: 2020

Journal Articles

Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo

Scott McCauley, Rakesh Verma, PhD, Martin Oft, MD PhD

Blood (2018) 132 (Supplement 1): 2058.

https://doi.org/10.1182/blood-2018-99-119359

Published: 2018

Journal Articles

Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders

Andrew Branagan, MD, Eamon Duffy, Connor Foster, Rakesh Verma, PhD, Lin Zhang, PhD, Geliang Gan, PhD, Fangyong Li, PhD, Madhav V Dhodapkar, MBBS

Blood (2017) 130 (Supplement 1): 438.

https://doi.org/10.1182/blood.V130.Suppl_1.438.438

Published: 2017

Journal Articles

Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Andrew R Branagan, MD, Eamon Duffy, Terri L Parker, MD, Stuart Seropian, MD, Connor Foster, Lin Zhang, Rakesh Verma, PhD(MDcal Oncology), MBA, MS, BCA, BS, Daniel Zelterman, PhD, Geliang Gan, PhD, Debra S. Brandt, DO, Jeremy Kortmansky, David H Witt, MD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD

Blood (2016) 128 (22): 2139.

https://doi.org/10.1182/blood.V128.22.2139.2139

Published: 2016

Journal Articles

Niche-Dependent Growth of Malignant and Pre-Neoplastic Plasma Cells in Humanized Mice

Rituparna Das, PhD, Till Strowig, PhD, Rakesh Verma, PhD, Srinivas Koduru, PhD, Anja Hafemann, PhD, Stephanie Hopf, Mehmet H. Kocoglu, MD, Chiara Borsotti, PhD, Lin Zhang, Andrew R Branagan, MD, Elizabeth Eynon, PhD, Markus Manz, MD, Richard Flavell, PhD, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 120.

https://doi.org/10.1182/blood.V126.23.120.120

Published: 2015

Journal Articles

Humanized Mouse Model of Myeloma Reveals Clinically Occult Genomic Changes in Primary Tumor Cells

Rakesh Verma, PhD, Till Strowig, PhD, Rituparna Das, PhD, Srinivas Koduru, PhD, Anja Hafemann, PhD, Stephanie Hopf, Mehmet H. Kocoglu, MD, Chiara Borsotti, PhD, Lin Zhang, Andrew R Branagan, MD, Elizabeth Eynon, PhD, Markus Manz, MD, Richard Flavell, PhD, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 22.

https://doi.org/10.1182/blood.V126.23.22.22

Published: 2015

Journal Articles

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Andrew R Branagan, MD, Eamon Duffy, Chandra Sekhar Boddupall, PhD, Randy A Albrecht, PhD, Lin Zhang, Rakesh Verma, PhD, Dennis L Cooper, MD, Stuart Seropian, MD, Terri L Parker, MD, Xiaopan Yao, PhD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 3058.

https://doi.org/10.1182/blood.V126.23.3058.3058

Published: 2015

Journal Articles

Identification of a Cereblon-Independent Protein Degradation Pathway in Residual Myeloma Cells Treated with Immunomodulatory Drugs

Rakesh Verma, PhD, Zifeng Mai, MS, Mina Xu, MD, Lin Zhang, Kavita Dhodapkar, MBBS, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 913.

https://doi.org/10.1182/blood.V126.23.913.913

Published: 2015

Journal Articles

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Kartik Sehgal, Rituparna Das, Lin Zhang, Rakesh Verma, Yanhong Deng, Mehmet Kocoglu, Juan Vasquez, Srinivas Koduru, Yan Ren, Maria Wang, Suzana Couto, Mike Breider, Donna Hansel, Stuart Seropian, Dennis Cooper, Anjan Thakurta, Xiaopan Yao, Kavita M. Dhodapkar, Madhav V. Dhodapkar

Blood (2015) 125 (26): 4042–4051.

https://doi.org/10.1182/blood-2014-11-611426

Published: 2015

Includes: Supplemental data

Journal Articles

Type II NKT-T FH cells against Gaucher lipids regulate B-cell immunity and inflammation

Shiny Nair, Chandra Sekhar Boddupalli, Rakesh Verma, Jun Liu, Ruhua Yang, Gregory M. Pastores, Pramod K. Mistry, Madhav V. Dhodapkar

Blood (2015) 125 (8): 1256–1271.

https://doi.org/10.1182/blood-2014-09-600270

Published: 2015

Includes: Supplemental data

Journal Articles

Type II NKT-TFH Cells Against Gaucher Lipids Regulate B Cell Immunity and Inflammation

Shiny Nair, PhD, Chandra Sekhar Boddupalli, PhD, Rakesh Verma, PhD, Jun Liu, Yang Ruhua, Gregory M Pastores, MD, Pramod Mistry, MD PhD FRCP, Madhav V. Dhodapkar, MD

Blood (2014) 124 (21): 755.

https://doi.org/10.1182/blood.V124.21.755.755

Published: 2014

Journal Articles

Enrichment Of Embryonal Stem Cell Signature and Persistent Genomic Complexity In Residual Disease Following Pomalidomide Therapy In Myeloma

Rakesh Verma, Ph.D, Kartik Sehgal, MBBS, Lin Zhang, Mehmet H. Kocoglu, MD, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 4200.

https://doi.org/10.1182/blood.V122.21.4200.4200

Published: 2013

Journal Articles

Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kavita Dhodapkar, MD, Lin Zhang, Rakesh Verma, Ph.D, Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 1949.

https://doi.org/10.1182/blood.V122.21.1949.1949

Published: 2013

Journal Articles

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Yanhong Deng, Rakesh Verma, Ph.D, Lin Zhang, Dennis L. Cooper, MD, Xiaopan Yao, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 3205.

https://doi.org/10.1182/blood.V122.21.3205.3205

Published: 2013

Journal Articles

Hematopoietic Lineage Selective Roles for Trib Pseudokinases Post Bone Marrow Transplantation.

Rakesh Verma, Ph.D, Arvind Dev, PhD, Don M. Wojchowski, PhD

Blood (2012) 120 (21): 2298.

https://doi.org/10.1182/blood.V120.21.2298.2298

Published: 2012

Journal Articles

Transcriptome- Based Analysis of EPO Dependent Cfu-e to Erythroblast Development

Rakesh Verma, Ph.D, Aishwarya Narayanan, PhD, David Kuhrt, PhD, Lei Li, PhD, Su Su, PhD, Ruth Asch, BA, Edward Jachimowicz, MS, Don M. Wojchowski, PhD

Blood (2012) 120 (21): 3188.

https://doi.org/10.1182/blood.V120.21.3188.3188

Published: 2012

Journal Articles

The Erythropoiesis Stimulating Agent Omontys/Peginesatide up-Modulates Erythroid Progenitor Formation, and Cell Surface Erythropoietin Receptor Levels.

Rakesh Verma, Ph.D, Jennifer M Green, PhD, Karen Leu, Richard B Mortensen, Peter R. Young, Peter J Schatz, Don M. Wojchowski, PhD

Blood (2012) 120 (21): 2089.

https://doi.org/10.1182/blood.V120.21.2089.2089

Published: 2012

Journal Articles

Erythropoietin-Directed Erythropoiesis Depends Upon Serpin Inhibition of Erythroblast Lysosomal Cathepsins

Don M. Wojchowski, PhD, Arvind Dev, PhD, Susan M Byrne, PhD, Rakesh Verma, Ph.D, Philip G Ashton-Rickardt, PhD

Blood (2012) 120 (21): 981.

https://doi.org/10.1182/blood.V120.21.981.981

Published: 2012

NARROW

Clinical Effectiveness and Long-Term Serologic Responses of COVID-19 Vaccination in Patients with Multiple Myeloma and Waldenström Macroglobulinemia

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy

Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo

Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders

Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Niche-Dependent Growth of Malignant and Pre-Neoplastic Plasma Cells in Humanized Mice

Humanized Mouse Model of Myeloma Reveals Clinically Occult Genomic Changes in Primary Tumor Cells

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Identification of a Cereblon-Independent Protein Degradation Pathway in Residual Myeloma Cells Treated with Immunomodulatory Drugs

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Type II NKT-T FH cells against Gaucher lipids regulate B-cell immunity and inflammation

Type II NKT-TFH Cells Against Gaucher Lipids Regulate B Cell Immunity and Inflammation

Enrichment Of Embryonal Stem Cell Signature and Persistent Genomic Complexity In Residual Disease Following Pomalidomide Therapy In Myeloma

Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Hematopoietic Lineage Selective Roles for Trib Pseudokinases Post Bone Marrow Transplantation.

Transcriptome- Based Analysis of EPO Dependent Cfu-e to Erythroblast Development

The Erythropoiesis Stimulating Agent Omontys/Peginesatide up-Modulates Erythroid Progenitor Formation, and Cell Surface Erythropoietin Receptor Levels.

Erythropoietin-Directed Erythropoiesis Depends Upon Serpin Inhibition of Erythroblast Lysosomal Cathepsins

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only